Objectives: Demonstration of the efficacy and safety of an herbal combination containing horseradish root and nasturtium herb for the treatment of uncomplicated, acute rhinosinusitis.
Design: Randomized, double-blind, placebo-controlled, two-arm, parallel group, multicenter, phase IV clinical study.
Setting: Sixteen centers in Germany, from October 2017 to March 2018.
Participants: Adult patients (≥18 – 75 years, male and female) diagnosed with uncomplicated, acute rhinosinusitis.
Interventions: Participants received the herbal combination or placebo (3 x 4 per day) for 14 days.
Clinical trial registration: EudraCT 2017-002081-40.
Endpoints: Primary endpoint was MRSSinv/MRSSpat documented between day 6 and day 10, computed as AUC, assessed by ANCOVA with day 3 as covariate. MRSSinv/MRSSpat, responder rates, efficacy assessment and SNOT-20 GAV were used as secondary endpoints.
Results: Out of 380 randomized participants, 238 were included in the FAS for statistical analysis. Treatment with the herbal combination revealed a significant smaller AUC (14.99) compared to placebo (18.52, p=0.0003). Moreover, MRSSinv/MRSSpat was significantly lower after administration of the herbal combination in comparison to placebo (3.60 herbal combination vs. 4.40 placebo, p=0.0018). Responder rates were significantly higher at visit 3 of patients receiving the herbal combination compared to placebo (92.1% herbal combination vs. 83.3% placebo, p=0.0418). Adverse events occurred in 21.9% and 18.6% of participants receiving the herbal combination and placebo, respectively. Most common adverse events were headaches and gastrointestinal complaints.
Conclusion: Efficacy and safety of the herbal combination in comparison to placebo were confirmed while the treatment was well tolerated.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.